Glycyrrhizin effectively neutralizes SARS-CoV-2 in vitro by inhibiting the viral main protease
Lukas van de Sand, Maren Bormann, Mira Alt, Leonie Schipper, Christiane Silke Heilingloh, Eike Steinmann, Daniel Tödt, Ulf Dittmer, Carina Elsner, Oliver Witzke, Adalbert Krawczyk
This study shows glycyrrhizin inhibits SARS-CoV-2 main protease and neutralizes the virus in vitro, suggesting it as a potential antiviral treatment for COVID-19.
Viruses · Apr 2, 2021Peer-reviewedMolecular Biology